Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession
Jon Green
•As a board of director for ERBI (Cambridge, UK) for many years, the current vice president of business operations for MedImmune (Gaithersburg, MD), Jon Green, will become the new Chairman for the organization.
Tammy Miller
•Now the new vice president of project management for ERT (Philadelphia, PA), Tammy Miller will hold the responsibility of globally implementing and delivering the company's project assurance methodology, which will include developing and executing strategic plans to enhance customer service.
Don Berg
•With the promotion of Don Berg to president of Clinical Supplies Management (Fargo, ND), who will now manage operations, sales, and finance divisions of the company, the role of chief executive officer has been given to Gerald Finken, who will now focus on business strategies and growth opportunities, including development of on-demand packaging and labeling.
Gerald Finken
•Appointed to the position of CRF's (Lansdale, PA) clinical advisor, Nadina Jose, MD, will gain the responsibility of providing clinical insight and site experience to clients and internal staff, as well as provide therapeutic training, industry white paper leadership, speak at industry conferences, and represent the company's special interest groups.
• BASi (West Lafayette, IN) has expanded its business development team in the United States with Don Hawker now representing the company in Canada and the Western United States, including California, Oregon, Washington, Idaho, Nevada, Utah, Montana, Arizona, and Wyoming.
•The former founding executive, president, and chief scientific officer of Quintiles Laboratories (Westmont, IL), Frank Morrow, PhD, is now the chief operating officer of LabConnect (Seattle, WA).
Professor So Iwata, an Imperial College London scientist, accepting his £2 million Diamond Fellowship from the Biotechnology and Biological Sciences Research Council.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.